Corium International Inc. (CORI) 10.96 $CORI Corium

New Post Public Reply Private Reply Replies (0) Message Board

May 14, 2015 at 7:04 PM

Corium International Inc. (CORI) 10.96 $CORI

Corium International's (CORI) CEO Peter Staple on Q2 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sun May 10, 4:04AM CDT

CORI: 10.96 (-0.44)

Corium reports 2Q loss
Automated Insights - Thu May 07, 6:07PM CDT
MENLO PARK, Calif. (AP) _ Corium International Inc. (CORI) on Thursday reported a fiscal second-quarter loss of $7.1 million, after reporting a profit in the same period a year earlier.
CORI: 10.96 (-0.44)

Corium misses by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu May 07, 3:56PM CDT

CORI: 10.96 (-0.44)

Corium Reports Second Quarter Fiscal 2015 Financial Results
GlobeNewswire - Thu May 07, 3:06PM CDT
Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited financial results from operations for both the second fiscal quarter and the six months ended March 31, 2015. Corium's fiscal year ends on September 30.
CORI: 10.96 (-0.44), SNSS: 2.33 (+0.01)

Corium International (CORI) Shows Strength: Stock Up 15.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 30, 7:51AM CDT
Corium International, Inc. (CORI) was a big mover last session, as its shares rose roughly 16% on the day
CORI: 10.96 (-0.44), AGRX: 11.49 (-0.12)

Corium to Report Second Quarter Fiscal 2015 Financial Results on Thursday, May 7, 2015
GlobeNewswire - Thu Apr 30, 7:00AM CDT
Corium International, Inc. (Nasdaq:CORI) today announced that it will report financial results for the Second Quarter Fiscal 2015 on Thursday, May 7, 2015 after the close of the U.S. financial markets. Corium will host a conference call and live audio webcast at 5:15 p.m. Eastern time, 2:15 p.m. Pacific time to discuss its financial results.
CORI: 10.96 (-0.44)

Aequus enters into CNS product development progarmmes in collaboration with Corium
M2 - Wed Apr 29, 4:48AM CDT
Specialist life sciences company Aequus Pharmaceuticals (TSXV:AQS.V) announced on Tuesday the launch of a collaboration agreement to co-fund new transdermal products, with an initial focus on neurological disorders, in partnership with Corium International (NasdaqGM:CORI).
CORI: 10.96 (-0.44), AQS.VN: 0.580 (-0.010)

Aequus and Corium Enter Into Product Development Collaboration Focused on CNS
Marketwired - Tue Apr 28, 3:06PM CDT
Aequus Pharmaceuticals Inc., (Aequus) (TSX VENTURE: AQS), a specialty life sciences company focused on providing patients with differentiated and enhanced delivery systems for existing and approved drugs, and Corium International, Inc. (Corium) (NASDAQ: CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, announced today that they have entered into a collaboration agreement under which the parties may co-fund new transdermal products with an initial focus on neurological disorders. Under the terms of this agreement, for each product selected for development the parties will assign an allocation of responsibilities, costs, rights and product revenues.
CORI: 10.96 (-0.44), AQS.VN: 0.580 (-0.010)

Joseph J. Sarret, M.D., J.D. Joins Corium as Chief Business Officer
GlobeNewswire - Tue Apr 28, 7:00AM CDT
Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Joseph J. Sarret, M.D., J.D. has joined the Company in the newly created position of Chief Business Officer. Reporting to Corium's President and Chief Executive Officer, Peter D. Staple, Dr. Sarret will serve as a member of the company's executive leadership team with responsibility for developing and implementing Corium's business strategies, building new alliances and expanding existing ones, and pursuing new business initiatives that leverage Corium's advanced transdermal technologies and product candidates.
CORI: 10.96 (-0.44)

Health Care Stock Check: Complementary Research on ARCA Biopharma, Great Basin, Corium International, Alphatech Holdings, Akers Biosciences
PR Newswire - Fri Apr 17, 7:15AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ATEC: 1.31 (unch), CORI: 10.96 (-0.44), GBSN: 3.22 (-0.30), GBSNU: 16.19 (-0.60), AKER: 4.20 (-0.47), ABIO: 0.84 (-0.02)

Is Corium International (CORI) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 16, 7:43AM CDT
Corium International is one stock that might be an intriguing choice for investors as it is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
CORI: 10.96 (-0.44)

Corium to Present at the 14th Annual Needham Healthcare Conference
GlobeNewswire - Thu Apr 02, 7:00AM CDT
Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced that Peter Staple, Corium's President and Chief Executive Officer, will present at the 14 Annual Needham Healthcare Conference on Wednesday, April 15, 2015 in New York City at The Westin New York Grand Central Hotel.
CORI: 10.96 (-0.44)

Corium Announces Appointment of Eric H. Bjerkholt to Board of Directors
GlobeNewswire - Wed Apr 01, 7:00AM CDT
Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced the appointment of Eric H. Bjerkholt to the Company's Board of Directors and as Chair of the Board's Audit Committee.
CORI: 10.96 (-0.44)

Corium incurs higher Q1 fiscal 2015 net loss of USD6.8m
M2 - Wed Feb 11, 5:03AM CST
Biopharmaceutical company Corium International (NasdaqGM:CORI) stated on Tuesday that recorded a net loss of USD6.8m (USD0.37 per share on a fully-diluted basis) for the first fiscal quarter ended 31 December 2014.
CORI: 10.96 (-0.44)

Corium misses by $0.13, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 3:24PM CST

CORI: 10.96 (-0.44)

Corium Reports First Quarter Fiscal 2015 Financial Results
GlobeNewswire - Tue Feb 10, 3:08PM CST
Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced unaudited financial results from operations for the first fiscal quarter ended December 31, 2014. Corium's fiscal years end on September 30.
CORI: 10.96 (-0.44)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tchah Sup Kim: A Retrospective at KCCNY in 2026

A Glimpse into Tchah Sup Kim's Legacy Stumble into the world of Tchah Sup Kim (1940–2022) this fall at the Korean Cultural Center New York. Kim's posthumous retrospective, "The Key to a New World," brings together over 130 of his works alongside archival materials, offering a comprehensive dive into a mind that spent decades between New York and Korea. The exhibit,...

Haag-Streit Debuts Innovative Octopus 910 Perimeter at AAO

Now here's something that'll tickle your ophthalmologist's fancy—Haag-Streit USA has rolled out the Octopus 910, a slick piece of kit set to shake up visual field testing for glaucoma management. This time, they're getting in front of the competition, unveiling it at the Association for Research in Vision and Ophthalmology's 2026 shindig in New Orleans. With this new...

Phoenix Scholar Examines AI and Institutional Trust

A Thoughtful Look at Trust and Technology We're staring at an issue here that dives deep into the guts of how technology, AI in particular, is reshaping our professional landscape. The latest issue of the Phoenix Scholar, a publication from the University of Phoenix College of Doctoral Studies, is tackling big questions. It's that kind of brainy reading where you untangle...

Amap, Sands China Unleash Tutu Robots for Resort Duty

Tutu Robots Usher in a New Technological Era for Sands China Alright, let's dive into some tech that feels out of a sci-fi movie and see what Sands China and Amap have cooked up as they introduce the Tutu robot dogs to Sands Resorts Macau. These aren't your run-of-the-mill gadgets—they're futuristic tour guides ready to rewire visitor experiences. The delivery ceremony...

tm:rw Revolutionizes Retail with Live TikTok Studios

tm:rw Takes a Bold Step into Social Commerce Throw out whatever you've thought about traditional brick-and-mortar retail because tm:rw isn't just bending the rules—it's burning the book. Launching nine branded studio spaces at their Times Square flagship, tm:rw is blending live streaming with in-person shopping, all in sync with TikTok Shop. The experience is less about...

Young Visionaries Win Junior Medals at STARMUS VIII

Fresh from the Canary Islands' shores, STARMUS VIII has lifted the veil on two young powerhouses shaping tomorrow—Valeria Corrales and Aneeshwar Kunchala. These two have snagged coveted honors, crowning them as champions of their generation. Igniting Passion for Science and the Environment Valeria Corrales isn't just another face in the crowd; she’s the force behind a...

Emdoor’s Rugged Devices Fuel Industry Growth Globally

Emdoor Information: A Sturdy Path in Rugged Computing Dive into the heart of the rugged computing terrain, and you may very well run into Emdoor Information—an 18-year-old titan from Shenzhen that’s carved its niche on the backs of rugged tablets, laptops, and handhelds. Publicly listed since 2023 on China’s A-share main board, Emdoor isn't just any player in this...

CenterPoint Deploys Crews for Hurricane Aid Relief

CenterPoint’s Commitment Amidst Crisis Now, when a hurricane slams into the coast, it’s go time for everyone in the game. CenterPoint Energy, never one to sit on the sidelines, is showing up with a hefty squad to help fix the mess left by Hurricane Isaias. A robust 355-strong team is heading out to assist with power restoration down there in Florida. This isn’t just...

Arrvel's Thermal Printers: Aiming at E-Com Sellers

Arrvel's Thermal Printing Push: An Overview No one would have pegged tiny thermal label printers as game-changers, but here we are. Arrvel's new lineup of thermal printers is shaking up the world for anyone who's ever had to slap on a shipping label or get inventory organized. They're targeting e-commerce folks and small businesses, which sounds like the right move as...

RingConn Smart Ring Gains Key FDA 510(k) Clearance

FDA Clearance: A Major Step for RingConn In a space where every tiny gadget-maker is desperately clawing for a regulatory nod, RingConn—a venture born from Shenzhen Ninenovo Technology Limited—has snagged an FDA 510(k) clearance (Clearance No. K260490) for their wearable Smart Ring that measures blood oxygen levels non-invasively. October 10, 2026, marked the day when...